Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers.
JCO precision oncology | 2022-02-01 | PMID 35108036
Garmezy Benjamin, Gheeya Jinesh, Lin Heather Y and 14 more
